Clinical trial Recruiting at 1 site Interventional Ages 3 to 12

Dexamethasone vs dexmedetomidine vs both to prolong popliteal nerve block pain relief in children

Official title: A Randomized, Double-Blinded, Controlled Trial Comparing Perineural Dexamethasone, Dexmedetomidine, and Their Combination as Adjuvants to Ropivacaine for Popliteal Sciatic Nerve Block in Pediatric Patients

Run by Poznan University of Medical Sciences · NCT07289620 · Data updated 2026-11-12

This trial will test whether adding dexamethasone, dexmedetomidine, or both to a popliteal nerve block gives children having lower-leg or foot surgery longer pain relief and reduces the need for extra pain medicine.

More Ankle Fractures trials

Quick facts

Study typeInterventional
Ages3 Years to 12 Years
SexAll
Enrollment120 (estimated)
SponsorPoznan University of Medical Sciences
Academic / other
Locations1 site (Poznan)
StatusRecruiting
StartedJanuary 16, 2026
Main results expectedJanuary 1, 2027
Study endsJanuary 31, 2027
Registry record updatedFebruary 2, 2026
Trial IDNCT07289620 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 3 to 12 years scheduled for elective unilateral lower-limb (foot, ankle, or distal lower leg) surgery with a planned popliteal sciatic nerve block, ASA I–III, whose parents/guardians can provide consent and participate in follow-up.

Probably not a fit

Children with known allergy to the study drugs, pre-existing lower-limb neurologic or neuromuscular disease, coagulopathy or anticoagulation, local infection at the block site, those outside the age range, or unable/unwilling to complete follow-up are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, double-blinded trial enrolls children aged 3–12 undergoing elective unilateral foot, ankle, or distal lower-leg surgery who will receive a single-shot popliteal sciatic nerve block with 0.2% ropivacaine. Participants are randomly assigned to receive perineural dexamethasone, dexmedetomidine, or the combination added to the local anesthetic, with patients, parents, and pain assessors blinded to group assignment. Trained observers will record pain scores, block duration, time to first rescue analgesia, opioid consumption, and recovery parameters. Follow-up includes telephone checks at 1 week and 1 month to capture pain control and any delayed issues.

Why it matters

Potential benefit: If successful, the combination could provide longer-lasting pain relief after surgery, reduce opioid requirements, and improve postoperative comfort for children.

How similar studies have gone: Prior adult and pediatric work shows that dexamethasone and dexmedetomidine individually prolong peripheral nerve block duration, but evidence on their combined perineural use is limited and mixed, especially in children.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Children aged 3 to 12 years.
* Scheduled for elective unilateral lower limb surgery (foot, ankle, or distal lower leg) under general anesthesia with a popliteal sciatic nerve block planned for postoperative analgesia.
* ASA physical status I-III.
* Ability of parents or legal guardians to understand the study procedures and provide written informed consent.
* Child and parents/guardians available for telephone follow-up at 1 week and 1 month after surgery.

Exclusion Criteria:

* Refusal of the parents/legal guardians to provide informed consent or refusal of the child to cooperate with anesthesia or study procedures.
* Known allergy or hypersensitivity to ropivacaine, dexamethasone, dexmedetomidine, or any component of the study medications.
* Pre-existing neurological deficit or neuromuscular disease affecting the lower limbs (motor or sensory).
* Coagulopathy or current therapeutic anticoagulation that contraindicates regional anesthesia.
* Local infection, inflammation, or skin lesions at the planned block site.
* Severe cardiac, hepatic, renal, or respiratory disease that, in the investigator's opinion, increases the risk of study participation.
* History of clinically significant arrhythmias, severe bradycardia, or second/third degree atrioventricular block not treated with a pacemaker.
* Developmental delay or severe cognitive impairment that precludes reliable pain assessment or follow-up.
* Chronic use of opioid analgesics or sedatives (≥ 2 weeks of daily use before surgery).
* Participation in another interventional clinical trial within the last 30 days.
* Any other condition considered by the investigator to interfere with protocol adherence, safety monitoring, or reliable outcome assessment.

Where it's running

  • Poznan University of Medical Sciences
    Poznan, Poland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.